The investigation of research in Stanford president Marc Tessier-Lavigne's lab will have major implications in elite science.
 BRIAN FRANK FOR STAT
Research misconduct allegations put Stanford's president — and science — under an uncomfortable spotlight The investigation of research in Stanford president Marc Tessier-Lavigne's lab will have major implications for the conduct of elite science. It's also resurfacing longstanding and thorny questions in research. How much blame should scientists bear for work that they don't produce but from which they clearly benefit? Is the pressure to publish splashy papers in top-tier journals driving researchers to cut corners? Read more. By Jonathan Wosen |
|
 CONSTANZA HEVIA FOR STAT
A devastating skin condition could soon get its first medication, as the frontiers of gene therapy expand Wounds have been a constant fact of Aaron Owens' life. His skin is so fragile that friction that would be trivial to others could scrape off his tissue. But his condition improved after participating in a clinical trial for the first gene therapy for a skin condition, which the FDA could soon approve. Read more. By Andrew Joseph
 KAREN PENNAR / STAT
With weight loss drug ads, telehealth companies wade into a regulatory gray area Companies have capitalized on new weight loss drugs by launching telehealth services dedicated to prescribing Wegovy and Ozempic. But their advertisements have swiftly raised questions about the oversight of direct-to-consumer advertising. Read more. By Mohana Ravindranath More great reads from STAT this week |
|
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2023, All Rights Reserved. | |
|
No comments